Clinical comprehensive evaluation of Shexiang Tongxin Dropping Pills
Based on literature and questionnaire research,related evidence and related data on Shexiang Tongxin Dropping Pills were collected in terms of safety,effectiveness,economy,innovation,suitability,and accessibility.In addition,multi-criteria decision analysis(MCDA)model was used to comprehensively evaluate the clinical value of Shexiang Tongxin Dropping Pills.Quality control was carried out strictly based on evidence-based medicine evaluation.Shexiang Tongxin Dropping Pills were recommended for stable fatigue angina of coronary heart disease with Qi deficiency and blood stasis by guidelines and experts.The conventional treatment of western medicine adds Shexiang Tongxin Dropping Pills to reduce the frequency of angina attacks,shorten the duration,improve exercise tolerance,and improve the quality of life and Chinese symptoms,and the effectiveness is rated as grade A.Adverse reactions are mostly general adverse reactions,and no serious adverse reactions have been reported,consistent with the known risks listed in the instruction for adverse events,contraindications,and precautions.The safety is rated as grade A,and the daily cost is 7.74 yuan.The cost-effectiveness shows that it is a treatment regimen with pharmacoeconomic advantages,and the economic performance is rated as grade A.According to specialist research,Shexiang Tongxin Dropping Pills have good clinical innovation and service innovation,and innovation is rated as grade A.There are no special storage conditions,medicinal material ingredients,or other restrictions,and the clinical use meets the specifications of the medication guidelines.The suitability is rated as grade A.The price level,availability,and affordability of drugs are generally good,and the accessibility is rated as grade A.The clinical value of Shexiang Tongxin Dropping Pills is great.
NETL
NSTL
万方数据
